https://www.selleckchem.com/MEK.html
valuation of this strategy in a phase III randomized trial. Bladder cancer metastasis seriously affects the prognosis of patients, but its molecular mechanism is unclear. This study sought to explore the roles of tissue factor pathway inhibitor-2 (TFPI-2) gene overexpression in the infiltration and metastasis of bladder cancer. Firstly, real-time PCR and immunohistochemistry were used to compare themRNA and protein expression levels, respectively, of TFPI-2 and matrix metalloproteinase-1 (MMP-1) in adjacent non-tumoral tissues, muscle-invasive bladd
Like
Comment
Share
